BackBrooklyn ImmunoTherapeutics Overview

Brooklyn ImmunoTherapeutics Total Assets

Brooklyn ImmunoTherapeutics's total assets is $940M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$938.97M
↓ 48.08% YoYΔ $-869.59M vs prior year quarter

Peer average

Loading

Brooklyn ImmunoTherapeutics Total Assets History

Loading

Brooklyn ImmunoTherapeutics vs. peers: Total Assets Comparison

Loading

Brooklyn ImmunoTherapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Brooklyn ImmunoTherapeutics (BTX) FAQ

As of the most recent data (December 2025), BTX shows a total assets of $940M. That compares with $1.8B in the prior-year period — down 48.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BTX's total assets is now $940M (was $1.8B) — a 48.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Brooklyn ImmunoTherapeutics is outperforming or lagging.

Tracking BTX's total assets over time shows whether Brooklyn ImmunoTherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $940M That compares with $1.8B in the prior-year period — down 48.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Brooklyn ImmunoTherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $940M) with ownership activity and broader fundamentals.

Brooklyn ImmunoTherapeutics's total assets is $940M; compare it with other Telecommunications names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.